Aceto Corp. (ACET) CEO Bill Kennally on Q1 2019 Results - Earnings Call Transcript

Stock Information for Aceto Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Aceto Corporation

ACETO Completes the Sale of Its Chemicals Business Assets
ACETO Completes the Sale of Rising Pharmaceuticals
New Mountain Capital Acquires ACETO Chemicals Business
ACETO to Sell its Chemicals Business Assets to New Mountain Capital
ACETO Receives Court Approval of "Stalking Horse" Agreement to Sell Rising Pharmaceuticals to Shore Suven Pharma, Inc.
ACETO Enters into "Stalking Horse" Agreement to Sell Rising Pharmaceuticals
ACETO Announces Receipt of Nasdaq Notice Due to Delay in Filing Form 10-Q for the Fiscal Quarter Ended December 31, 2018
ACETO Announces Proposed Sale of its Chemicals Business Assets to New Mountain Capital for $338 million

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.